Bliss GVS Pharma Limited has informed the Exchange about General Updates
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anupam Rasayan India Limited has signed a Share Purchase Agreement to acquire 43.30% stake (4,58,03,024 shares) in Bliss GVS Pharma Limited from promoter and non-promoter sellers for ₹1,370 crore at ₹299 per share. This acquisition crosses the 25% threshold, triggering a mandatory open offer under SEBI regulations. The open offer seeks to purchase up to 2,77,26,848 additional shares (26% of expanded voting capital) at the same price of ₹299 per share, potentially totaling ₹829 crore. Upon completion, Anupam Rasayan will hold up to 69.51% of Bliss GVS, gaining control and becoming the new promoter. Existing promoters will be reclassified from promoter to public category. The offer is all-cash with no minimum acceptance condition and no delisting intention.
This represents a change of control transaction where Anupam Rasayan India Limited will become the new promoter of Bliss GVS Pharma. Existing shareholders can tender shares at ₹299 per share, which is 26% above the trigger. The market price will likely react to this acquisition news.